Sign in to view content

Extended Q16W Dosing Potential for Faricimab in Neovascular Age-Related Macular Degeneration (nAMD): STAIRWAY Phase 2 Trial

Philip J. Ferrone, MD, FASRS

Video
Published 2019

Phillip J. Ferrone, MD

AMD Neovascular Part I Symposium

Related

Diabetic Retinopathy Progression in Anti-VEGF Versus Fluocinolone Acetonide Implant Treated Eyes Who Are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2020
BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Annual Meeting Talks
2019
Endophthalmitis Rates After Bilateral Same Day Intravitreal Anti-VEGF Injections
Durga Borkar, MD
Updates from the Field
2018

Category: AMD-Neovascular

See more